CLINICAL_TRIALS trial_result · 2023-05-09

Clinical Trial Update: A Phase II Study in Adult Patients With Moderate to Severe Atopic Dermatitis [Phase 2]

Phase II study in adults with moderate to severe atopic dermatitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Reistone Biopharma Company Limited | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2023-05-09